Marvel Biosciences Corp.
MRVL.V
TSX
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/30/2025
-
MarketBeat
11/6/2025
-
Proactive Investors - UK
11/6/2025
-
GuruFocus
11/6/2025
-
Proactive Investors - UK
11/6/2025
-
GuruFocus
11/6/2025
-
Market News Video
11/6/2025
-
GuruFocus
11/6/2025
-
Invezz News
11/6/2025
-
GuruFocus
11/6/2025
-
Nasdaq News: ETFs
11/6/2025
-
ETF Channel
11/6/2025
-
MarketBeat
11/6/2025
-
MarketBeat
11/6/2025
-
Ticker Report
11/6/2025
-
Tickeron - Stocks
11/6/2025
-
GuruFocus
11/6/2025
-
SeekingAlpha.com: All News
11/6/2025
-
GuruFocus
11/6/2025
-
The Japan Times
11/5/2025
-
MarketBeat
11/5/2025
-
Zacks Investment Research
11/5/2025
-
Seeking Alpha - Long Ideas
11/5/2025
-
SeekingAlpha
11/5/2025
-
MarketBeat
10/6/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, June 17, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Nov 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
403 770 2469
Address
505 8th Avenue S.W.
Calgary, AB T2P 1G2
Calgary, AB T2P 1G2
Country
Year Founded
--
Business Description
Sector
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound...
more